Design of a dual aptamer-based recognition strategy for human matrix metalloproteinase 9 protein by piezoelectric biosensors

Analytica Chimica Acta

Volumn 897, Issue , 2015, Pages 1-9

  Scarano, S ^a   Dausse, E ^b   Crispo, F ^a,c   Toulme J J ^b   Minunni, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF BASILICATA   (Italy)

Author keywords

Aptamer; Aptasensor; Human matrix metalloproteinase 9; Human serum; Piezoelectric biosensor

Indexed keywords

BODY FLUIDS; DIAGNOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; PIEZOELECTRICITY; PROTEINS;

APTAMERS; APTASENSOR; HUMAN MATRIX; HUMAN SERUM; PIEZOELECTRIC BIOSENSORS;

BIOSENSORS;

APTAMER; GELATINASE B; IMMUNOGLOBULIN G; MMP9 PROTEIN, HUMAN; PEPTIDE APTAMER;

ARTICLE; BIOSENSOR; CONTROLLED STUDY; HUMAN; LIMIT OF DETECTION; MOLECULAR RECOGNITION; PIEZOELECTRIC BIOSENSOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SERUM; CHEMISTRY; EQUIPMENT DESIGN; GENETIC PROCEDURES; METABOLISM; SYNTHESIS;

APTAMERS, PEPTIDE; BIOSENSING TECHNIQUES; EQUIPMENT DESIGN; HUMANS; MATRIX METALLOPROTEINASE 9;

EID: 84945483227     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2015.07.009     Document Type: Article

References (69)

1. Vargová V., Pytliak M., Mechírová V. Matrix metalloproteinases. Matrix Metalloproteinase Inhibitors - Specificity of Binding and Structure-activity Relationships 2012, 1-33. Springer, Basel. S.P. Gupta (Ed.).
2. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
3. Sekhon B.S. Matrix metalloproteinases - an overview. Res. Rep. Biol. 2010, 1:1-20.
4. Ramos-De Simone N., Hahn-Dantona E., Sipley J., Nagase H., French D.L., Quigley J.P. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 1999, 274:13066-13076.
5. Halade G.V., Jin Y., Lindsey M.L. Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol. Ther. 2013, 139:32-40.
6. Rybakowski J.K. Matrix metalloproteinase-9 (MMP9)-a mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders. Cardiovasc. Psychiatry Neurol. 2009, 2009. ID: 904836.
7. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 2002, 37:375-536.
8. Rivera S., Khrestchatisky M., Kaczmarek L., Rosenberg G.A., Jaworski D.M. Metzincin proteases and their inhibitors, foes or friends in nervous system physiology?. J. Neurosci. 2010, 30:15337-15357.
9. Lorenzl S., Albers D.S., LeWitt P.A., Chirichigno J.W., Hilgenberg S.L., Cudkowicz M.E., Beal M.F. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J. Neurol. Sci. 2003, 207:71-76.
10. Chaturvedi M., Kaczmarek L. MMP-9 inhibition: a therapeutic strategy in ischemic stroke. Mol. Neurobiol. 2014, 49:563-573.
11. Romi F., Helgeland G., Gilhus N.E. Serum levels of matrix metalloproteinases: implications in clinical neurology. Eur. Neurol. 2012, 67:121-128.
12. Itoh T., Matsuda H., Tanioka M., Kuwabara K., Itohara S., Suzuki R. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J. Immunol. 2002, 169:2643-2647.
13. Rai B., Kharb S., Jain R., Anand S.C. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J. Oral Sci. 2008, 50:53-56.
14. Wysocki A.B., Staiano-Coico L., Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol. 1993, 101:64-68.
15. Medina C., Radomski M.W. Role of matrix metalloproteinases in intestinal inflammation. J. Pharmacol. Exp. Ther. 2006, 318:933-938.
16. Catania J.M., Chen G., Parrish A.R. Role of matrix metalloproteinases in renal pathophysiologies. Am. J. Physiol. Ren. Physiol. 2007, 292:F905-F911.
17. Chakrabarti S., Patel K.P. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp. Lung Res. 2005, 31:599-621.
18. Gupta S.P., Patil V.M. Specificity of binding with matrix metalloproteinases. Matrix Metalloproteinase Inhibitors - Specificity of Binding and Structure-activity Relationships 2012, 35-56. Springer, Basel. S.P. Gupta (Ed.).
19. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer metast. Rev. 2006, 25:9-34.
20. Ray J.M., Stetler-Stevenson W.G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 1994, 7:2062-2072.
21. Roomi M.W., Monterrey J.C., Kalinovsky T., Rath M., Niedzwiecki A. Distinct patterns of matrix metalloproteinase-2 and -9 expression in normal human cell lines. Oncol. Rep. 2009, 21:821-826.
22. Riedel F., Götte K., Schwalb J., Hörmann K. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinom. Anticancer Res. 2000, 20:3045-3049.
23. Capper S., Evans V., Hanemaaijer R., Sully H., Visser H., Verheijen J. A novel assay for MMP-9 activity-correlation with ELISA and application to biological fluid measurements. Life Sci. News 1999, 2:1-2.
24. Vadillo-Ortega F., González-Avila G., Furth E.E., Lei H., Muschel R.J., Stetler-Stevenson W.G., Strauss J.F. 92-kd type IV collagenase (Matrix Metalloproteinase-9) activity in human amniochorion increases with labor. Am. J. Pathol. 1995, 146:148-156.
25. Hanemaaijer R., Van Lent N., Visser H., Verheijen J. Methods to increase the sensitivity of the MMP-9 activity assay. Life Sci. News 1999, 3:8-9.
26. Hawkins K.E., DeMars K.M., Yang C., Rosenberg G.A., Candelario-Jalil E. Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke. Mol. Brain 2013, 6:1-11.
27. Knight C.G., Willenbrock F., Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 1992, 296:263-266.
28. St-Pierre Y., Desrosiers M., Tremblay P., Estève P.O., Opdenakker G. Flow cytometric analysis of gelatinase b (mmp-9) activity using immobilized fluorescent substrate on microspheres. Cytometry 1996, 25:374-380.
29. Lombard C., Saulnier J., Wallach J. Assays of matrix metalloproteinases (MMPs) activities: a review. Biochimie 2005, 87:265-272.
30. Lauer-Fields J.L., Nagase H., Fields G.B. Development of a Solid-Phase Assay for Analysis of Matrix Metalloproteinase Activity. J. Biomol. Tech. 2004, 15:305-316.
31. Prely L.M., Paal K., Hermans J., van der Heide S., van Oosterhout A.J.M., Bischoff R. Quantification of matrix metalloprotease-9 in bronchoalveolar lavage fluid by selected reaction monitoring with microfluidics nano-liquid-chromatography-mass spectrometry. J. Chromatogr. A 2012, 1246:103-110.
32. Wang Y., Zagorevski D.M., Lennartz M.R., Loegering D.J., Stenken J.A. Detection of in vivo matrix metalloproteinase activity using microdialysis sampling and liquid chromatography-mass spectrometry. Anal. Chem. 2009, 81:9961-9971.
33. Mannello F. Effects of blood collection methods on gelatin zymography of matrix metalloproteinases. Clin. Chem. 2003, 49:339-340.
34. Gogly B., Groult N., Hornebeck W., Godeau G., Pellat B. Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. Anal. Biochem. 1998, 255:211-216.
35. Snoek-van Beurden P.A.M., Von den Hoff J.W. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques 2005, 38:73-83.
36. Choi J.H., Kim H., Choi J.H., Choi J.W., Oh B.K. Signal enhancement of silicon nanowire-based biosensor for detection of matrix metalloproteinase-2 using DNA-Au nanoparticle complexes. Appl. Mater. Inter. 2013, 5:12023-12028.
37. Jiang F., Zhang J.J., Zhang J.R., Zhu J.J. Ultrasensitive immunoassay based on dual signal amplification of the electrically heated carbon electrode and quantum dots functionalized labels for the detection of matrix metalloproteinase-9. Analyst 2013, 138:1962-1965.
38. Shi J.J., He T.T., Jiang F., Abdel-Halim E.S., Zhu J.J. Ultrasensitive multi-analyte electrochemical immunoassay based on GNR-modified heated screen-printed carbon electrodes and PS@PDA-metal labels for rapid detection of MMP-9 and IL-6. Biosens. Bioelectron. 2014, 55:51-56.
39. Shabani A., Tabrizian M. Design of a universal biointerface for sensitive, selective, and multiplex detection of biomarkers using surface plasmon resonance imaging. Analyst 2013, 138:6052-6062.
40. Pieper-Fürst U., Kleuser U., Stöcklein W.F.M., Warsinke A., Scheller F.W. Detection of subpicomolar concentrations of human matrix metalloproteinase-2 by an optical biosensor. Anal. Biochem. 2004, 332:160-167.
41. Pieper-Fürst U., Stöcklein W.F.M., Warsinke A. Gold nanoparticle-enhanced surface plasmon resonance measurement with a highly sensitive quantification for human tissue inhibitor of metalloproteinases-2. Anal. Chim. Acta 2005, 550:69-76.
42. Shoji A., Kabeya M., Sugawara M. Real-time monitoring of matrix metalloproteinase-9 collagenolytic activity with a surface plasmon resonance biosensor. Anal. Biochem. 2011, 419:53-60.
43. Wang Y., Shen P., Li C., Wang Y., Liu Z. Upconversion fluorescence resonance energy transfer based biosensor for ultrasensitive detection of matrix metalloproteinase-2 in blood. Anal. Chem. 2012, 84:1466-1473.
44. Soumetz F.C., Pastorino L., Ruggiero C. Development of a piezoelectric immunosensor for matrix metalloproteinase-1 detection. Conf. Proc. IEEE Eng. Med. Biol. Soc 2009, 2009:2775-2778.
45. Zhen S.J., Zhuang H.L., Wang J., Huang C.Z. Dual-aptamer-based sensitive and selective detection of prion protein through the fluorescence resonance energy transfer between quantum dots and graphene oxide. Anal. Methods 2013, 5:6904-6907.
46. Bai Y., Feng F., Zhao L., Wang C., Wang H., Tian M., Qin J., Duan Y., He X. Aptamer/thrombin/aptamer-AuNPs sandwich enhanced surface plasmon resonance sensor for the detection of subnanomolar thrombin. Biosens. Bioelectron. 2013, 47:265-270.
47. Shiratori I., Akitomi J., Boltz D.A., Horii K., Furuichi M., Waga I. Selection of DNA aptamers that bind to influenza A viruses with high affinity and broad subtype specificity. Biochem. Biophys. Res. Commun. 2014, 443:37-41.
48. Goda T., Higashi D., Matsumoto A., Hoshi T., Sawaguchi T., Miyahara Y. Dual aptamer-immobilized surfaces for improved affinity through multiple target binding in potentiometric thrombin biosensing. Biosens. Biolelectron. 2015, 73:174-180.
49. Han K., Liang Z., Zhou N. Design Strategies for Aptamer-Based Biosensors. Sensors 2010, 10:4541-4557.
50. Deng B., Lin Y., Wang C., Li F., Wang Z., Zhang H., Li X.F., Le X.C. Aptamer binding assays for proteins: the thrombin example - a review. Anal. Chim. Acta 2014, 837:1-5.
51. Brockman L., Wang R., Lum J., Li Y. QCM aptasensor for rapid and specific detection of avian influenza virus. Open J. Appl. Biosens. 2013, 2:97-103.
52. Bora U., Sett A., Singh D. Nucleic acid based biosensors for clinical applications. Biosens. J. 2013, 1:1-8.
53. Song K.M., Lee S., Ban C. Aptamers and their biological applications. Sensors 2012, 12:612-631.
54. Hong P., Li W., Li J. Applications of aptasensors in clinical diagnostics. Sensors 2012, 12:1181-1193.
55. Luzi E., Minunni M., Tombelli S., Mascini M. New trends in affinity sensing: aptamers for ligand binding. Trends Anal. Chem. 2003, 22:810-818.
56. Banerjee J. Antibodies are challenged. Indian J. Med. Sci. 2010, 64:144-147.
57. Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 1999, 45:1628-1650.
58. Song S., Wang L., Li J., Zhao J., Fan C. Aptamer-based biosensors. Trend Anal. Chem. 2008, 27:108-117.
59. Zimbres F.M., Tárnok A., Ulrich H., Wrenger C. Aptamers: novel molecules as diagnostic markers in bacterial and viral infections?. Biomed. Res. Int. 2013, 2013:1-7.
60. Da Rocha Gomes S., Miguel J., Azeḿa L., Eimer S., Ries C., Dausse E., Loiseau H., Allard M., Toulmé J.J. (99m)Tc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9. Bioconjug. Chem. 2012, 23:2192-2200.
61. Mannelli I., Minunni M., Tombelli S., Wang R., Spiriti M.M., Mascini M. Direct immobilisation of DNA probes for the development of affinity biosensors. Bioelectrochemistry 2005, 66:129-138.
62. O'Sullivan C.K., Guilbault G.G. Commercial quartz crystal microbalances - theory and applications. Biosens. Bioelectron. 1999, 14:663-670.
63. Tombelli S., Bini A., Minunni M., Mascini M. Piezoelectric biosensors for aptamer-protein interaction. Methods Mol. Biol. 2009, 504:23-36.
64. Di Primo C., Dausse E., Toulmè J.J. Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions. Methods Mol. Biol. 2011, 764:279-300.
65. Tombelli S., Mascini M., Turner A.P.F. Improved procedures for immobilisation of oligonucleotides on gold-coated piezoelectric quartz crystals. Biosens. Bioelectron. 2002, 17:929-936.
66. Baldrich E., Restrepo A., O'Sullivan C.K. Aptasensor development: elucidation of critical parameters for optimal aptamer performance. Anal. Chem. 2004, 76:7053-7063.
67. Minunni M., Tombelli S., Gullotto A., Luzi E., Mascini M. Development of biosensors with aptamers as bio-recognition element: the case of HIV-1 Tat protein. Biosens. Bioelectron. 2004, 20:1149-1156.
68. Bini A., Centi S., Tombelli S., Minunni M., Mascini M. Development of an optical RNA-based aptasensor for C-reactive protein. Anal. Bioanal. Chem. 2008, 390:1077-1086.
69. Mariani S., Minunni M. Surface plasmon resonance applications in clinical analysis. Anal. Bioanal. Chem. 2014, 406:2303-2323.